Paradigm has results from its Phase 2 hay fever trial pending in six weeks.
ACCESS THE FULL PRESENTATION HERE
The start of 2017 has seen some good trial results for its skin cancer treatment, as well as a collaboration deal that will accelerate the development of its lung cancer drug
The US-based, London-listed healthcare group topped expectations with its latest results and analysts are tipping it for more success this year
Dr Andrew Beehag talked medical cannabis products and pathways with investors.